This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Ruiz-Irastorza, G Articles by Hughes, G R. Search for Related Content PubMed PubMed Citation Articles by Ruiz-Irastorza, G Articles by Hughes, G R. Social Bookmarking                         What's this?

Lupus pregnancy: is heparin a risk factor for osteoporosis?

Lupus Research Unit, The Rayne Institute, St Thomas' Hospital, London, UK; Service of Internal Medicine, Hospital de Cruces, Bizkaia, Spain

M A Khamashta

Lupus Research Unit, The Rayne Institute, St Thomas' Hospital, London SE1 7EH, UK 106404.2325{at}Compuserve.com

C Nelson-Piercy

Department of Obstetrics, Guy's and St Thomas' Trust, London, UK

G RV Hughes

Lupus Research Unit, The Rayne Institute, St Thomas' Hospital, London, UK

Regulation of calcium homeostasis during pregnancy is complex. Clinically significant bone mass loss is infrequent; however a subset of women may develop symptomatic osteoporosis related to pregnancy. Lactation is a period of special risk for bone loss. Whatever the effect of heparin on bone loss, vertebral fractures are rare in women treated with heparin during pregnancy. Low molecular weight heparins may have a less deleterious effect on bone than unfractionated heparin. Women with autoimmune diseases, particularly those with lupus and/or the antiphospholipid syndrome may receive heparin throughout pregnancy. Corticosteroids must be reduced as much as possible in these women, and calcium plus vitamin D are recommended. Finally, indications for heparin use must be clearly justified and advice regarding breastfeeding must be offered.

Key Words: thrombosis • miscarriage • anticoagulants • antiphospholipid

Lupus, Vol. 10, No. 9, 597-600 (2001)
DOI: 10.1191/096120301682430168


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				E. Lefkou, M. Khamashta, G. Hampson, and B. Hunt Review: Low-molecular-weight heparin-induced osteoporosis and osteoporotic fractures: A myth or an existing entity? Lupus, January 1, 2010; 19(1): 3 - 12. [Abstract] [PDF]

				G Ruiz-Irastorza and M. Khamashta Lupus and pregnancy: ten questions and some answers Lupus, May 1, 2008; 17(5): 416 - 420. [PDF]

				H. S. Nielsen and O. B. Christiansen Prognostic impact of anticardiolipin antibodies in women with recurrent miscarriage negative for the lupus anticoagulant Hum. Reprod., June 1, 2005; 20(6): 1720 - 1728. [Abstract] [Full Text] [PDF]

				M. A. Smythe, W. E. Dager, and N. M. Patel Managing Complications of Anticoagulant Therapy Journal of Pharmacy Practice, October 1, 2004; 17(5): 327 - 346. [Abstract] [PDF]

				G Ruiz-Irastorza, M A Khamashta, and G R. Hughes Heparin and osteoporosis during pregnancy: 2002 update Lupus, October 1, 2002; 11(10): 680 - 682. [Abstract] [PDF]